AU2003238440A1 - Regulation of human adenylate cyclase, type ii - Google Patents

Regulation of human adenylate cyclase, type ii

Info

Publication number
AU2003238440A1
AU2003238440A1 AU2003238440A AU2003238440A AU2003238440A1 AU 2003238440 A1 AU2003238440 A1 AU 2003238440A1 AU 2003238440 A AU2003238440 A AU 2003238440A AU 2003238440 A AU2003238440 A AU 2003238440A AU 2003238440 A1 AU2003238440 A1 AU 2003238440A1
Authority
AU
Australia
Prior art keywords
regulation
type
adenylate cyclase
human adenylate
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003238440A
Inventor
Mayumi Hayashi
Toshio Kokubo
Ningshu Liu
Yoshihisa Manabe
Noriko Ohnishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003238440A1 publication Critical patent/AU2003238440A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2003238440A 2002-05-31 2003-05-30 Regulation of human adenylate cyclase, type ii Abandoned AU2003238440A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38459602P 2002-05-31 2002-05-31
US60/384,596 2002-05-31
PCT/EP2003/005690 WO2003102175A1 (en) 2002-05-31 2003-05-30 Regulation of human adenylate cyclase, type ii

Publications (1)

Publication Number Publication Date
AU2003238440A1 true AU2003238440A1 (en) 2003-12-19

Family

ID=29712062

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003238440A Abandoned AU2003238440A1 (en) 2002-05-31 2003-05-30 Regulation of human adenylate cyclase, type ii

Country Status (2)

Country Link
AU (1) AU2003238440A1 (en)
WO (1) WO2003102175A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2095701A (en) * 1999-12-14 2001-06-25 Millennium Pharmaceuticals, Inc. 25678, a novel human adenylate cyclase
WO2002038747A2 (en) * 2000-11-13 2002-05-16 Bayer Aktiengesellschaft Human adenylate cyclase

Also Published As

Publication number Publication date
WO2003102175A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
AU2003296586A1 (en) Pyridazinone derivatives as cdk2-inhibitors
AU2003259249A1 (en) Pyridazinylpiperazine derivatives for treating pain
AU2003223096A1 (en) Artificial muscle
AU2002341195A1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
AU2002312883A1 (en) Substituted cyclohexane-1,4-diamine derivatives
TWI319400B (en) Piperazinylacylpiperidine derivatives, their preparation and their therapeutic application
AU2003202091A1 (en) Guanidine derivatives
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003283500A1 (en) 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors
AU2002367987A1 (en) Shoulder adjuster
AU2003282755A1 (en) Methods of regulating body weight
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AU7860800A (en) Adenylate cyclase
HK1075045A1 (en) 1,3,5-Triazine derivatives as ligands for human adenosine-a3 receptors
IL162524A0 (en) Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
AU2002359052A1 (en) Composition for skin whitening
AU2002237228A1 (en) Regulation of human adenylate cyclase, type vii
AU2003238440A1 (en) Regulation of human adenylate cyclase, type ii
AU2002337179A1 (en) Regulation of human type i adenylate cyclase
AU2002215029A1 (en) Regulation of human adenylate cyclase, type iv
AU2003269950A1 (en) Heteroaryl-ethanolamine derivatives as antiviral agents
AU1502902A (en) Regulation of human adenylate cyclase, type iv
AU2003250329A1 (en) Regulation of novel human asparagine-hydroxylases
AU2003297136A1 (en) Novel selective algaecides for control of cyanochloronta
AU2003304151A1 (en) Heteroaryl-ethanolamine derivatives as antiviral agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase